Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx zahraničních xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 bylo generálním xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx úmluvy xxxxx xxxxxxx xx sportu¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx xxxxx x xxxxx dopingu.

Xxxxxxx X xxxxxxxxx x platnost x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. ledna 2008 x xxxxx xxxx vstoupila v xxxxxxxx x xxx Xxxxxx republiku. Xxxx xxxxxx Xxxxxxx X x platnost xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx proti xxxxxxx xx xxxxxx xx xxxxx pro xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. m. x.

Xxxxxxxx znění Xxxxxxx X x její xxxxxxx xx českého xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX XXXXX

Xxxxxxxxxx látky xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (AAS):

x. Xxxxxxxx * XXX, zahrnující:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-norandrostendiol); xxxxxxxxxx; xxxxxxxx; xxxxxxx (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; xxxxxxxxxxxxx (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; xxxxxxxxxx; furazabol (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); kalusteron; xxxxxxxxx; xxxxxxxxxx; mesterolon; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx); xxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9,11-trien-3-on); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); norboleton; xxxxxxxxxxxxxx; xxxxxxxxxxxx; xxxxxxxx; oxandrolon; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-hydroxy-5α-androst-1-en-3-on); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

b. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), testosteron x následující metabolity x xxxxxxx:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-androstan-3β,17α-diol 5-androstendion (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

androst-4-en-3α,17α-diol 3α-hydroxy-5αandrostan-17-on

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, kdy xxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx steroid xxxxxxxxx, xxxx xx xxx xx xx, xx Xxxxxx obsahuje tuto Xxxxxxxxx xxxxx a xxxx xxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx x/xxxx když xx jakýkoli jiný xxxxxxxxx xxxxx xx Xxxxxx Sportovce xxxxxxxx xxxxxxxxx xx rozmezí xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx xxx, xx xxxxxxxxxx normální xxxxxxxxx xxxxxxxx. Nebude xx xxx za xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx v xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx nebo xxxxxxxxxx x/xxxx příslušný xxxxx xx Xxxxxx Sportovce xxxxxxxx fyziologickým nebo xxxxxxxxxxxx stavem.

Xxxx xx mít xx xx, xx Xxxxxx Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x laboratoř xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx xx všech xxxxxxxxx a při xxxxxxxxx xxxxxxxxxxx, xxxxx xxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxx, že xx Xxxxxxxx látka xxxxxxxxxx xxxxxx. V xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Když xx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx neodchylují xx xxxxxxx hodnot, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx a xxxxx xxxxxxxxxx analytická xxxxxx (např. IRMS) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, jako xxxx. xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxx když xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx xxx xxxxx (4) xx xxxxx (1) a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, xxxxxxx příslušná Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx nebo xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx xxxxxxxxxx xxxxxx xxxxx šetření, xxx xxxxxxxx bude xxxxxxxxxx xxxxxx xxxx xxxxxxxxx x ne jako xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx metody (xxxx. IRMS) xxxxxxxx xxxxx Zakázané xxxxx, xxxx xxxxx provádět xxxxx xxxxxxx, x xxxx xx xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx xxxxx. Xxxxx xxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) x nejsou x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx tím, xx xxxx příslušnou Xxxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx xxx předchozího xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, xxxx hlášen xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx, xxxxxxxx následnými xxxxx, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx pak xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx být x xxxx xxxxxx xxxxxxx xxxxxxxx endogenního xxxxxx ve velice xxxxxx xxxxxxxxxxxxx (ng/ml). Xxxxx xxxxxxxxx xxxxxx xxxxx nahlásila x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, xxxx xxx provedeno další xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx xxxxxxxxx nahlásila Xxxxxxxxx xxxxxxxxxxx nález 19-xxxxxxxxxxxxxxx, xxxx xx xx považovat xx xxxxxxx x xxxxxxxxxxx xxxxx exogenního xxxxxx Xxxxxxxx látky. X xxxxxxx xxxxxxx není xxxxx provádět xxxxx xxxxxxx.

V případě, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx při xxxxxxx xxxxxxxxx, xxxx se xxx xx xx, xx Vzorek Xxxxxxxxx xxxxxxxx Zakázanou xxxxx.

2. Xxxxxxx xxxxxxxxxx xxxxx, zahrnující:

Xxxxxxxxxxx, xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (SARM), xxxxxxx, xxxxxxx, zilpaterol, xxx xx x xxxxxxxx xxxxx na ně.

X2. XXXXXXX A XXXXXXXX XXXXX

Xxxxxxxxxxx látky x jejich uvolňující xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxxxx (XXX);

2. Růstový xxxxxx (xXX), xxxxxxxx xxxxxxx xxxxxxx faktory (xxxx. XXX-1), mechanické xxxxxxx xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), xxxxxxxx jen x mužů;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x další xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx účinky.

Xxxxx Xxxxxxxxx xxxxxx xxxxxxxx, xx koncentrace xxxx xxxxxxxxx fyziologickým či xxxxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx xx uvedeno xxxx) v případech, xxx xxxxxxxxxxx Zakázané xxxxx nebo xxxxxx xxxxxxxxxx xx indikátorů x/xxxx xxxxxxxxx xxxxxx xx Xxxxxx Sportovce xxxxxxx překročí xxxxxxx xxxxxxxx zjištěné x xxxx tak, xx xxxxxxxxxxxx xxxxxxxx endogenní xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, xx užití xxxxxxxxxx analytické metody, xx Xxxxxxxx látka xx xxxxxxxxxx xxxxxx, xxxx se mít xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx a xxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X3. XXXX-2 XXXXXXXX

Všichni xxxx-2 xxxxxxxx včetně xxxxxx D- a X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxxx, pro které xx xxx inhalaci xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxxx.

X xxxx xxxx xxxxxxx xxxxxxxx forma terapeutické xxxxxxx, bude nález xxxxxxxxxxx (volný plus xxxxxxxxxx) vyšší xxx 1000 xxxxxxxxx x 1 mililitru xxxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx, pokud Xxxxxxxxx xxxxxxxxx, že xxxxxxxxxx xxxxxxxx xxx xxxxxxxx terapeutickým xxxxxxxx xxxxxxxxxxx x inhalaci.

X4. XXXXXXXXXXX X MODULÁTORY XXXXXXX

Xxxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Xxxxxxxxxx modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

4. Xxxxx modifikující xxxxxx xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, ale xx x omezením xxxxx xx ně.

X5. DIURETIKA X XXXXXXX MASKOVACÍ LÁTKY

Xxxxxxxxx xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, dextran, xxxxxxxxxxxxxxxxx) x další xxxxx x xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, metolazon, xxxxxxxxxxxxx, xxxxxxxx (xxxx. bendroflumethiazid, xxxxxxxxxxxxxxxxxx, chlorothiazid), triamteren x další xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Terapeutická xxxxxxx xxxx xxxxxx, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx xxxxxxxxxxx xxxxxxxx xxxx Zakázané látky (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Zakázané xx xxxxxxxxxxx:

M2. XXXXXXXX X XXXXXXXXX MANIPULACE

M3. XXXXXX XXXXXX

Neterapeutické xxxxxxx buněk, xxxx, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx xxxxxxx genů, xxxxx xxxx xxxxxxxxx xxxxxx xxxxxxxxx xxxxx, xx xxxxxxxx.

X6. STIMULANCIA

Všechna xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx xxxxxxxxx (X- x X-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx v případě xxxxxx místního xxxxx x xxxxxxxxxxx xxxxxxxxxx xx Monitorovacího xxxxxxxx xxx xxx 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, benzfetamin, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, efedrin****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, fendimetrazin, fenetylin, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-fenylpiracetam (karfedon), xxxxxxxxxx, heptaminol, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, mefentermin, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), metylefedrin****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, modafinil, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x další xxxxx x podobnou xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx výslovně xxxx xxxxxxxx v xxxxx xxxxxx bude xxxxxxxxxx xx xxxxxxxxxxx xxxxx pouze, xxxxx Xxxxxxxxx prokáže, xx xxxx xxxxxxxxx xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx neúmyslné xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxx xx x xxx menší xxxxxxxxxxxxxxx, xx xxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx deriváty, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (např. xxxxx, xxxxxxxxx) jsou xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx xxxxxxxxxxxxxxxxxxxx xxxxxxxx orálně, xxxxxxxx, xxxxxxxxxx xxxx nitrosvalovou xxxxxxxx jsou xxxxxxxx. Xxxxxx xxxxx vyžaduje xxxxxxxxxxxxx xxxxxxx.

Jiné xxxxxxx injekční aplikace (xxxxxxxxxxxx, xx xxxxx xxxxxx, xx xxxxx xxxxxx, epidurální, xx xxxx) x inhalační xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxx s xxxxxxxx níže xxxxxxxxx.

Xxxxxxx xxxxxxxxx podávané xx xxxxxx xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, xxxx, xxxxxx xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx x xxxxx nejsou xxxxxxxx x xxxxxxxxxx žádnou xxxxx xxxxxxxxxxxx xxxxxxx.

P1. XXXXXXX

Alkohol (xxxxxx) xx xxxxxxxx xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx provádět xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx xxxxxxx x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Letecké xxxxxx x parašutismus (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 g/l)

∙ Moderní xxxxxxx (XXXX) xxx pro xxxxxxxxxx xx xxxxxxxx (0.10 x/x)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 x/x)

∙ Xxxxx motorismus (XXX) (0.30 g/l)

∙ Xxxxxxx (XXX) (0.10 x/x)

X2. BETA-BLOKÁTORY

Xxxxx xxxx xxxxx určeno, xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx Při soutěži x xxxxxxxxxxxxx xxxxxxxx.

∙ Xxxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx a xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Mimo soutěž)

∙ Xxxxxxxx (FIS) - skoky xx xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x snowboard X-xxxxx x "xxx air"

∙ Moderní xxxxxxx (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Petanque x xxxxxxx sporty (XXXX, XXX "xxxxx")

∙ Střelba (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx motorismus (UIM)

∙ Xxxxx (FILA)

Xxxx-xxxxxxxxx xxxxxxxx následující xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, bisoprolol, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, metipranolol, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, sotalol, xxxxxxx, xxx xx s xxxxxxxx pouze xx xx

"Xxxxxxxxxx látky"* xxxx xxxxxxxxxxx xxxx:

∙ Xxxxxxx Xxxx-2 xxxxxxxx v xxxxxxxx, xxxxx xxxxxxxxxxx (volného xxxx xxxxxxxxxxx) xxx xxxxxxxx xxxxxx než 1000 ng/ml moči x xxxxxxxxxxxx (xxxxxxx xx skupině X 1.2 Xxxxxxx anabolické xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, meklofenoxát, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxx x xxxxxxx xxxxxxx stimulancia xxxxxxxxx xxxxxxxx v xxxxxx X6, xxx která Xxxxxxxxx prokáže, xx xxxxxxx xxxxxxxx xxxxxxx x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx být vyjmenovány xxxxxxxxxx látky, které xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx antidopingových pravidel, xxxxxxx xxxx všeobecně xxxxxxxx v xxxxxxx xxxxxxxxx xxxxxxxxxxx, nebo x nichž xx xxxxx pravděpodobnost, xx xxxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx látky xxxx xxxxxxxx xxxxxxx xxxxxx xx předpokladu, xx "...Xxxxxxxxx xxxx xxxxx prokázat, xx Xxxxxxx specifické xxxxx xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx výkonu...".

Xxxxxx xxxxxxx x. 2/2008 Xx. m. x. xxxxx xxxxxxxxx xxxx 31.1.2008.

Xxxxxx xxxxxxx č. 2/2008 Xx. m. x. xxx zrušen xxxxxxx předpisem č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační xxxxx shora uvedeného xxxxxxxx předpisu.